Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies (Q39968883)

16 September 2017

Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies (English)

1 reference

16 September 2017

0 references

2

1 reference

16 September 2017

Brian T Helfand

1

1 reference

16 September 2017

Qiaoyan Hu

3

1 reference

16 September 2017

Phillip R Cooper

4

1 reference

16 September 2017

Kimberly A Roehl

5

1 reference

16 September 2017

Barry B McGuire

6

1 reference

16 September 2017

Nikola A Baumann

7

1 reference

16 September 2017

William J Catalona

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

27 February 2013

1 reference

16 September 2017

1 reference

16 September 2017

189

1 reference

16 September 2017

5

1 reference

16 September 2017

1697-1701

1 reference

Prostate-cancer mortality at 11 years of follow-up

16 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Infectious complications and hospital admissions after prostate biopsy in a European randomized trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Genetic correction of PSA values using sequence variants associated with PSA levels

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

22 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Prostate specific antigen best practice statement: 2009 update.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Screening and prostate-cancer mortality in a randomized European study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Multiple newly identified loci associated with prostate cancer susceptibility

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Heritability of cardiovascular and personality traits in 6,148 Sardinians

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631301

Cumulative association of five genetic variants with prostate cancer

2 December 2018

1 reference

12 December 2020

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA

1 reference

12 December 2020

Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level

1 reference

12 December 2020

Prostate biopsy and optimization of cancer yield

1 reference

12 December 2020

Heritability of prostate-specific antigen and relationship with zonal prostate volumes in aging twins

1 reference

12 December 2020

Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin

1 reference

12 December 2020

10.1016/J.JURO.2012.12.023

Identifiers

DOI

1 reference

16 September 2017

1 reference

16 September 2017

PubMed publication ID

23246478

1 reference